Searchable abstracts of presentations at key conferences in endocrinology

ea0063p240 | Pituitary and Neuroendocrinology 1 | ECE2019

Pituitary stalk interruption syndrome: an uncommon presentation

Eugenia Lopez Valverde Maria , Florencio Ojeda Luna , Martin Lopez Manuel , Isabel Rebollo Perez Maria

Pituitary stalk interruption syndrome (PSIS) is a rare clinical entity characterised by an absent or thin pituitary stalk, hypoplasia of the anterior pituitary gland, and ectopic location of the posterior pituitary on magnetic resonance imaging (MRI). Presentation is on early childhood or puberty and the most common hormonal deficiencies are growth hormone (GH) and gonadotropines. We present the case of a 28-year-old female patient who consulted after 2 years in secondary amen...

ea0049gp111 | Diabetes therapy & complications 2 | ECE2017

Hepatic effects of GLP-1 receptor agonist Liraglutide in patients with type 2 diabetes

Hayon Maria , Fernandez Marta , Maraver Silvia , Muros Teresa , Cepero Daniel , Lopez Martin , Quesada Miguel , Pechuan Joaquin , Piedrola Gonzalo

Introduction: The aim of this study was to analyze the effects of Liraglutide in hepatic steatosis as well as clinical and biochemical data before and after 6 months.Methods: We have retrospectively analysed epidemiological, anthropometric and laboratory data of 83 type 2 diabetic patients treated with Liraglutide and followed at different endocrinology units across east Andalusia. We have evaluated nonalcoholic fatty liver disease using liver enzymes an...

ea0037ep1085 | Endocrine tumours | ECE2015

Insulinoma: a multicentre and retrospective analysis of the Spanish experience during three decades

Iglesias Pedro , Lafuente Christian , Almendra Maria Angeles Martin , Lopez-Guzman Antonio , Castro Jose Carlos , Diez Juan Jose

Objective: To characterise insulinoma diagnosed and treated in the period 1983–2014 in various hospitals in Spain.Methods: Inclusion criteria were the presence of biochemical and morphological criteria compatible with insulinoma and/or histologic demonstration of tumour.Results: Twenty-nine patients (23 women (79.3%); mean age 48.7±17.4 years (range, 16–74)) were recruited. In 26 (89.7%) cases the tumor was sporadic ...

ea0032p383 | Diabetes | ECE2013

Study of the development and validation of the specific “Satiglu” questionnaire to evaluate the satisfaction of diabetic patients with glucometers

Portillo Cristobal Morales , Garcia Clara Garcia , Sanlaureano Florentino Carral , Huerga Juan Carlos , Casares Martin Lopez de la Torre , Hurtado Javier

Objective: To develop a specific questionnaire to evaluate the satisfaction of diabetic patients with the use of glucometers and evaluate their psychometric properties (feasibility, reliability, and validity).Material and methods: Two stages: i) questionnaire development: a set of 53 items was constructed after a bibliographic review. A panel of six experts and 50 patients concluded a 25-item version of the questionnaire (dimensions: satisfaction, inconv...

ea0063p215 | Diabetes, Obesity and Metabolism 1 | ECE2019

Lipodistrophy, a rare disease: ‘If you don’t think about it, you doesn’t diagnose it’

Ortega Rodriguez Pilar , Valverde Lopez ME , Lopez Martin M , Mayorga Roldan E , Perez Rebollo I , Salas Carrasco Pilar , Vilar Araujo D

Introduction: In the geographical area of southern Spain, in the province of Huelva, we have detected prevalent cases of Dunnigan’s partial hereditary lipodystrophy. The genealogy, the suspicion phenotype and the coordination with the Genetics Service and Reference center, have borne fruit, and more and more families are detected in Our Area. The lipodystrophies, in general, are rare diseases that affect the adipose tissue, disappearance of it in different parts of the bo...

ea0049ep581 | Diabetes therapy | ECE2017

The role of sodium-glucose co-transporter 2 inhibitors as add-on therapy in type 2 diabetes

Ponce Maria Hayon , Blanquez Martinez David , Jimenez Maria Jose Jimenez , Cordova Rossana Sofia Manzanares , Laguna Maria del Carmen Serrano , Charneco Miguel Quesada , Casares Martin Lopez de la Torre

Objective: SGLT2 inhibitors, have been shown to improve glycaemic control, stabilize insulin dosing and mitigate insulin-associated weight gain in patients whose type 2 diabetes mellitus (T2DM) was inadequately controlled. The objective is to evaluate the real-world efficacy and safety of adding iSGLT-2 therapy in inadequately controlled patients with oral antidiabetic drugs and with or without insulin therapy.Materials and methods: This observational st...